Drug ID: | NPD2370 |
Drug Name: | |
Molecular Formula: | C17H16Cl2O4 |
Canonical SMILES: | OC(=O)Cc1cc(Cl)c(c(c1)Cl)Oc1ccc(c(c1)C(C)C)O |
Standard InCHI: | InChI=1S/C17H16Cl2O4/c1-9(2)12-8-11(3-4-15(12)20)23-17-13(18)5-10(6-14(17)19)7-16(21)22/h3-6,8-9,20H,7H2,1-2H3,(H,21,22) |
Standard InCHIKey: | OZYQIQVPUZANTM-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DND000063; DND000101 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 9863447 |
ChEBI | |
CAS Number |
Molecular Weight | 354.04 |
ALogP | 1.2421 |
MLogP | 2.67 |
XLogP | 4.331 |
HDA | 2 |
HBD | 2 |
Rotatable Bonds | 11 |
TPSA | 66.76 |
RO5 Violation | 0 |